Supportive Care in Cancer

, Volume 21, Issue 10, pp 2663–2670 | Cite as

The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation

A single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care
  • Maarten Lambrecht
  • Carole Mercier
  • Yasmyne Geussens
  • Sandra Nuyts
Original Article



Mucosal damage is an important and debilitating side effect when treating head and neck cancer patients with (chemo-)radiation. The aim of this randomized clinical trial was to investigate whether the addition of a neutral, supersaturated, calcium phosphate (CP) mouth rinse benefits the severity and duration of acute mucositis in head and neck cancer patients treated with (chemo)radiation.

Materials and methods

A total of 60 patients with malignant neoplasms of the head and neck receiving (chemo)radiation were included in this study. Fifty-eight patients were randomized into two treatment arms: a control group receiving standard of care (n = 31) and a study group receiving standard of care + daily CP mouth rinses (n = 27) starting on the first day of (chemo-)radiation. Oral mucositis and dysphagia were assessed twice a week using the National Cancer Institute common toxicity criteria scale version 3, oral pain was scored with a visual analogue scale.


No significant difference in grade III mucositis (59 vs. 71 %; p = 0.25) and dysphagia (33 vs. 42 %, p = 0.39) was observed between the study group compared to the control group. Also no significant difference in time until development of peak mucositis (28.6 vs. 28.7 days; p = 0.48), duration of peak mucositis (22.7 vs. 24.6 days; p = 0.31), recuperation of peak dysphagia (20.5 vs 24.2 days; p = 0.13) and occurrence of severe pain (56 vs. 52 %, p = 0.5).


In this randomized study, the addition of CP mouth rinse to standard of care did not improve the frequency, duration or severity of the most common acute toxicities during and early after (chemo)radiation. There is currently no evidence supporting its standard use in daily practice.


Head and neck cancer Calcium phosphate rinse Chemoradiation Radiotherapy Mucositis Oral care 


  1. 1.
    Elting LS, Cooksley CD, Chambers MS et al (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68:1110–1120CrossRefPubMedGoogle Scholar
  2. 2.
    Barasch A, Peterson DE (2003) Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39:91–100CrossRefPubMedGoogle Scholar
  3. 3.
    Russo G, Haddad R, Posner M et al (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 13:886–898CrossRefPubMedGoogle Scholar
  4. 4.
    Peterson DE, Bensadoun RJ, Roila F (2011) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 22(Suppl 6):vi78–vi84CrossRefPubMedGoogle Scholar
  5. 5.
    Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831CrossRefPubMedGoogle Scholar
  6. 6.
    Rosenthal DI, Trotti A (2009) Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19:29–34CrossRefPubMedGoogle Scholar
  7. 7.
    Clarkson JE, Worthington HV, Furness S et al. (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2010; CD001973-Google Scholar
  8. 8.
    Hensley ML, Hagerty KL, Kewalramani T et al (2009) American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127–145CrossRefPubMedGoogle Scholar
  9. 9.
    Papas AS, Clark RE, Martuscelli G et al (2003) A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 31:705–712CrossRefPubMedGoogle Scholar
  10. 10.
    Wasko-Grabowska A, Rzepecki P, Oborska S et al (2011) Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 43:3111–3113CrossRefPubMedGoogle Scholar
  11. 11.
    Stokman MA, Burlage FR, Spijkervet FK (2012) The effect of a calcium phosphate mouth rinse on (chemo) radiation induced oral mucositis in head and neck cancer patients: a prospective study. Int J Dent Hyg 10:175–180PubMedGoogle Scholar
  12. 12.
    Sonis ST, Elting LS, Keefe D et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025CrossRefPubMedGoogle Scholar
  13. 13.
    Vagliano L, Feraut C, Gobetto G et al (2011) Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT—results of a multicentre study. Bone Marrow Transplant 46:727–732CrossRefPubMedGoogle Scholar
  14. 14.
    Sanguineti G, Sormani MP, Marur S et al (2012) Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 83:235–242CrossRefPubMedGoogle Scholar
  15. 15.
    Narayan S, Lehmann J, Coleman MA et al (2008) Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy. Int J Radiat Oncol Biol Phys 72:756–762CrossRefPubMedGoogle Scholar
  16. 16.
    Vera-Llonch M, Oster G, Hagiwara M et al (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106:329–336CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Maarten Lambrecht
    • 1
  • Carole Mercier
    • 1
  • Yasmyne Geussens
    • 1
    • 2
  • Sandra Nuyts
    • 1
    • 3
  1. 1.Department of Radiation-OncologyUniversity Hospitals LeuvenLeuvenBelgium
  2. 2.Department of RadiotherapyIridium Cancer Network, GZA Sint AugustinusWilrijkBelgium
  3. 3.Department of Radiation-OncologyUniversity Hospitals LeuvenLeuvenBelgium

Personalised recommendations